Regulatory/Agencies/HSA
🇸🇬Health Sciences Authority

HSA NAMs Framework

Singapore's HSA accepts NAMs data through ACSS consortium and serves as Asia's regulatory hub with bilateral agreements with major agencies.

ACSS
Consortium
Hub
Asia Pacific
2024
Guidance
MRA
Agreements
Written by J Radler | Patient Analog
Last updated: January 2025

Regulatory Highlights

  • Current regulatory framework and acceptance pathways
  • Compliance requirements for NAMs submissions
  • International harmonization through ICH guidelines
  • Practical guidance for regulatory strategy

Singapore as Asia's Regulatory Hub

HSA positions Singapore as a leading regulatory hub in Asia, with progressive policies toward NAMs acceptance and strong international partnerships.

ACSS Consortium Benefits

As an ACSS member, HSA participates in work-sharing arrangements:

  • Joint Reviews: Shared assessment with Australia, Canada, Switzerland
  • Reference Agency: Expedited pathways for FDA/EMA-approved NAMs
  • Scientific Advice: Coordinated guidance available

Related Agencies

🇦🇺 TGA Australia🇯🇵 PMDA Japan🇺🇸 FDA

© 2025 Patient Analog. All rights reserved.

Educational content created by J Radler for the biotech and scientific community. Last updated: February 4, 2026.

Free to share for educational purposes with attribution.